Invention Grant
US08969403B2 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
有权
结晶形式的3- [2-甲磺酰基-1-（4-三氟甲基 - 苯氧基）乙基]吡咯烷化合物
![Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound](/docs/US/2015-03-03/US08969403B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
- Patent Title (中): 结晶形式的3- [2-甲磺酰基-1-（4-三氟甲基 - 苯氧基）乙基]吡咯烷化合物
-
Application No.: US14149147Application Date: 2014-01-07
-
Publication No.: US08969403B2Publication Date: 2015-03-03
- Inventor: Pierre-Jean Colson , Timothy Fass , Venkat R. Thalladi
- Applicant: Pierre-Jean Colson , Timothy Fass , Venkat R. Thalladi
- Applicant Address: US CA South San Francisco
- Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah; Shelley Eberle
- Main IPC: A01N37/34
- IPC: A01N37/34 ; A61K31/275 ; A01N41/10 ; A61K31/10 ; C07D207/46 ; C07D295/00 ; C07D207/08
![Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound](/abs-image/US/2015/03/03/US08969403B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides crystalline hydrochloride salts of (S)-3-[(S)-2-methanesulfonyl-1-(4-trifluoromethylphenoxy)ethyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salts, processes and intermediates for preparing the crystalline salts, and methods of using the crystalline salts to treat diseases.
Public/Granted literature
- US20140121385A1 CRYSTALLINE FORMS OF A 3-[2-METHANESULFONYL-1-(4-TRIFLUOROMETHYL-PHENOXY)ETHYL]PYRROLIDINE COMPOUND Public/Granted day:2014-05-01
Information query
